Idiopathic Inflammatory Myopathies
📧 Sign up to get email alerts when something new happens for Idiopathic Inflammatory Myopathies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating BAFF-R CAR-T cell therapy for refractory neuroimmune diseases is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
An early Phase 1 clinical trial is evaluating UTAA91 Injection for relapsed/refractory autoimmune diseases. The study is not yet recruiting …
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: AYLo - AutoimmunitY and Loss of y
Clinical trial AYLo from the University of Bonn investigates autoimmunity across multiple diseases and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
This clinical trial update describes a study aiming to predict diverse glucocorticoid toxicity outcomes across inflammatory rheumatic diseas…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: A Study of Imvotamab in Active, Refractory Idiopathic Inflammatory Myopathies [Phase 1]
A Phase 1 study of Imvotamab in active, refractory idiopathic inflammatory myopathies has been terminated (Status: TERMINATED).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Adult Autoimmune Myopathies (MAIA) [NA]
Clinical trial MAIA investigates adult autoimmune inflammatory myopathies. The study is currently recruiting at University Hospital, Brest.
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Optimizing Treatment on Idiopathic Inflammatory Myopathies
A clinical trial at the University of Sao Paulo is currently recruiting to investigate treatments for Idiopathic Inflammatory Myopathies.
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System [EARLY_Phase 1]
An early-phase clinical trial is investigating CT103A cell therapy for relapsed/refractory antibody-associated inflammatory diseases of the …
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases [Phase 2]
A Phase 2 clinical trial update for rediscovering a drug for rare immune-mediated inflammatory diseases, with recruitment ongoing for Behçet…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
A preliminary Phase 1 study is planned to evaluate UTAA09 injections for relapsed/refractory autoimmune diseases, with recruitment not yet s…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis [Phase 2, Phase 3]
Clinical trial update reporting results for sodium thiosulfate in calcinosis associated with dermatomyositis, with Phase 2 and Phase 3 studi…
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM [Phase 2]
A Phase 2 clinical trial evaluating baricitinib (JAK1/2 inhibitor) for adult idiopathic inflammatory myopathies has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of Froniglutide (PF1801) in patients with idiopathic inflammatory myopathies, in…
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Clinical Characteristics and Mechanism Research of Inhibitors of Janus Kinase in the Idiopathic Inflammatory Myopathies [Phase 2]
Phase 2 clinical trial update investigating Janus kinase inhibitors in idiopathic inflammatory myopathies, focusing on characteristics and m…
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid [Phase 3]
Phase 3 clinical trial comparing denosumab vs zoledronic acid for bone mineral density in patients with idiopathic inflammatory myopathies a…